{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:16:48Z","timestamp":1789535808883,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["113S202"],"award-info":[{"award-number":["113S202"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.yexmp.2019.104280","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T10:23:52Z","timestamp":1561803832000},"page":"104280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-\u03b2 in the mesangial proliferative glomerulonephritis therapy"],"prefix":"10.1016","volume":"110","author":[{"given":"Saadet","family":"Alan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"\u015ealva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smet","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna \u00d6zba\u015f","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fclide","family":"Akbu\u011fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2019.104280_bb0005","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.yexcr.2012.02.025","article-title":"Mesangial cell biology","volume":"318","author":"Abboud","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexmp.2019.104280_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.carbpol.2012.03.014","article-title":"Antioxidant and renoprotective activity of chitosan in nephrectomized rats","volume":"89","author":"Anraku","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.yexmp.2019.104280_bb0015","doi-asserted-by":"crossref","first-page":"i45","DOI":"10.1093\/ndt\/gft273","article-title":"PDGF and the progression of renal disease","volume":"29","author":"Boor","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexmp.2019.104280_bb0020","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1152\/ajprenal.00343.2009","article-title":"Darbepoetin-treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model","volume":"299","author":"Ca\u00f1adillas","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0025","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1159\/000127359","article-title":"The regulation of mesangial cell proliferation","volume":"108","author":"Cove-Smith","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1620\/tjem.210.145","article-title":"Agmantine suppresses mesangial cell proliferation by modulating polyamine metabolism","volume":"210","author":"Eto","year":"2006","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.yexmp.2019.104280_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","article-title":"A new look at platelet-derived growth factor in renal disease","volume":"19","author":"Floege","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.yexmp.2019.104280_bb0040","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mt.2009.91","article-title":"The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice","volume":"17","author":"Gao","year":"2009","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.yexmp.2019.104280_bb0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.7150\/thno.7866","article-title":"Megalin-mediated specific uptake of chitosan\/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing","volume":"4","author":"Gao","year":"2014","journal-title":"Theranostics"},{"issue":"17","key":"10.1016\/j.yexmp.2019.104280_bb0050","first-page":"2","article-title":"Shenhua tablet inhibits mesangial cell proliferation in rats with chronic anti-Thy-1 nephritis","volume":"49","author":"Geng","year":"2016","journal-title":"Biol. Res."},{"key":"10.1016\/j.yexmp.2019.104280_bb0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/ki.1994.360","article-title":"Trapidil inhibits human mesangial cell proliferation: effect on PDGF a-receptor binding and expression","volume":"46","author":"Gesualdo","year":"1994","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.yexmp.2019.104280_bb0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1470320312466127","article-title":"Targeting reduction of proteinuria in glomerulonephritis: maximizing the antifibrotic effect of valsartan by protecting podocytes","volume":"15","author":"Gu","year":"2014","journal-title":"J. Renin-Angiotensin Aldosterone Syst."},{"issue":"878","key":"10.1016\/j.yexmp.2019.104280_bb0065","first-page":"1","article-title":"Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexmp.2019.104280_bb0070","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.ki.5000353","article-title":"Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis","volume":"70","author":"Huang","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2019.104280_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.yexmp.2005.11.005","article-title":"TGF-\u03b21 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction","volume":"81","author":"Hwang","year":"2006","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0080","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ki.2009.43","article-title":"Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis","volume":"75","author":"Iyoda","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2019.104280_bb0085","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ndt\/gfs414","article-title":"Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis","volume":"28","author":"Iyoda","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexmp.2019.104280_bb0090","first-page":"297","article-title":"Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model)","volume":"12","author":"Jefferson","year":"1999","journal-title":"J. Nephrol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0095","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.lfs.2005.08.037","article-title":"Up-regulation of integrin-linked kinase activity in rat mesangioproliferative glomerulonephritis","volume":"78","author":"Kagami","year":"2006","journal-title":"Life Sci."},{"issue":"123","key":"10.1016\/j.yexmp.2019.104280_bb0100","first-page":"2","article-title":"Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology-a systematic review","volume":"9","author":"Klopfleisch","year":"2013","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.yexmp.2019.104280_bb0105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1681\/ASN.2010020177","article-title":"siRNA therapy for glomerulonephritis","volume":"21","author":"Kreidberg","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0110","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.redox.2017.11.012","article-title":"Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS\/NF\u03baB\/mTOR\/P70S6K signaling cascade","volume":"14","author":"Lu","year":"2018","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.yexmp.2019.104280_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0017929","article-title":"Activation of src mediates PDGF-induced Smad1 phosphorylation and contributes to the progression of glomerulosclerosis in glomerulonephritis","volume":"6","author":"Mima","year":"2011","journal-title":"PlosOne"},{"key":"10.1016\/j.yexmp.2019.104280_bb0120","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0047-6374(01)00387-6","article-title":"Effects of antioxidants on kidney disease","volume":"123","author":"Mune","year":"2002","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.yexmp.2019.104280_bb0125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1681\/ASN.V125909","article-title":"Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis","volume":"12","author":"Ostendorf","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0130","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/eji.200939264","article-title":"Apoptosis of glomerular mesangial cells induced by sublytic C5b-9 complexes in rats with Thy-1 nephritis is dependent on Gadd45c upregulation","volume":"39","author":"Qiu","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.yexmp.2019.104280_bb0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1674-8301(11)60053-5","article-title":"TSP-1 promotes glomerular mesangial cell proliferation and extracellular matrix secretion in Thy-1 nephritis rats","volume":"25","author":"Qiu","year":"2011","journal-title":"J. Biomed. Res."},{"issue":"3","key":"10.1016\/j.yexmp.2019.104280_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.12991\/mpj.20162082721","article-title":"In vitro PDGF-B gene silencing studies and in vivo delivery of siRNA to the rat kidney using chitosan\/siRNA nanoplexes","volume":"20","author":"\u015ealva","year":"2016","journal-title":"Marmara Pharm. J."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104280_bb0145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1208\/s12249-016-0687-8","article-title":"The inhibition of glomerular mesangial cell proliferation by siPDGF-B and siPDGFR\u03b2 containing chitosan nanoplexes","volume":"18","author":"\u015ealva","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.yexmp.2019.104280_bb0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2004.09.042","article-title":"Nephrin expression is increased in anti-thy 1.1-induced glomerulonephritis in rats","volume":"324","author":"Schaefer","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexmp.2019.104280_bb0155","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.addr.2010.08.011","article-title":"Mesangial pathology in glomerular disease: targets for therapeutic intervention","volume":"62","author":"Scindia","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexmp.2019.104280_bb0160","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1681\/ASN.2009030295","article-title":"siRNA-based therapy ameliorates glomerulonephritis","volume":"21","author":"Shimizu","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.yexmp.2019.104280_bb0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2173","article-title":"Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?","volume":"7","author":"Sotiriou","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.yexmp.2019.104280_bb0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.ackd.2010.03.010","article-title":"CKD and ESRD in the elderly: current prevalence, future projections, and clinical significance","volume":"17","author":"Stevens","year":"2010","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.yexmp.2019.104280_bb0175","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.addr.2010.07.005","article-title":"Application of siRNA in targeting protein expression in kidney disease","volume":"62","author":"Stokman","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yexmp.2019.104280_bb0180","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2007.08.189","article-title":"Chemically modified siRNA prolonged RNA interference in renal disease","volume":"363","author":"Takabatake","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.yexmp.2019.104280_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/0886022X.2015.1120097","article-title":"Arellano-Mendoza M.G., a review of the impact of oxidative stress and some antioxidant therapies on renal damage","volume":"38","author":"Tamay-Cach","year":"2016","journal-title":"Ren. Fail."},{"key":"10.1016\/j.yexmp.2019.104280_bb0190","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1096\/fj.08-109488","article-title":"Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B","volume":"22","author":"Venkatesan","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.yexmp.2019.104280_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000335750","article-title":"ACE inhibition in anti-Thy1 glomerulonephritis limits proteinuria but does not improve renal function and structural remodeling","volume":"2","author":"Westerweel","year":"2012","journal-title":"Nephron Extra."},{"issue":"4","key":"10.1016\/j.yexmp.2019.104280_bb0200","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.kint.2016.03.041","article-title":"Nanomedicines for kidney diseases","volume":"90","author":"Williams","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexmp.2019.104280_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1359-6446(05)03668-8","article-title":"Harnessing in vivo siRNA delivery for drug discovery and drug development","volume":"11","author":"Xie","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yexmp.2019.104280_bb0215","first-page":"178","article-title":"Protective effects of chitosan oligosaccharide and its derivatives against carbon tetrachlorideinduced liver damage in mice","volume":"35","author":"Yan","year":"2006","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.yexmp.2019.104280_bb0220","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7150\/thno.9717","article-title":"Chitosan\/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction- induced kidney injury in mice","volume":"5","author":"Yang","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.yexmp.2019.104280_bb0225","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.fct.2007.09.111","article-title":"Effects of chitosan oligosaccharide (COS) on the glycerol-induced acute renal failure in vitro and in vivo","volume":"46","author":"Yoon","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0230","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.fct.2011.04.036","article-title":"Protective effects of chitosan oligosaccharide on paraquat-induced nephrotoxicity in rats","volume":"49","author":"Yoon","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yexmp.2019.104280_bb0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10611860701289875","article-title":"Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier","volume":"15","author":"Yuan","year":"2007","journal-title":"J. Drug Target."},{"key":"10.1016\/j.yexmp.2019.104280_bb0240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1021\/mp800078a","article-title":"Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan","volume":"6","author":"Yuan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.yexmp.2019.104280_bb0245","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3892\/etm.2014.1643","article-title":"Effect of erythropoietin loading chitosan-tripolyphosphate nanoparticles on an IgA nephropathy rat model","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2019.104280_bb0250","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1053\/j.ackd.2013.06.003","article-title":"Targeting therapeutics to the glomerulus with nanoparticles","volume":"20","author":"Zuckerman","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"2","key":"10.1016\/j.yexmp.2019.104280_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/nat.2014.0505","article-title":"siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA","volume":"25","author":"Zuckerman","year":"2012","journal-title":"Nuc. Acid Ther."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019300528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019300528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:52:03Z","timestamp":1757991123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480019300528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":50,"alternative-id":["S0014480019300528"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.104280","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-\u03b2 in the mesangial proliferative glomerulonephritis therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.104280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104280"}}